Related Experiment Videos

Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host

F P Nestel1, K S Price, T A Seemayer

  • 1Department of Physiology, McGill University, Montreal, Quebec, Canada.

Insights

Graft-versus-host disease (GVHD) primes macrophages, leading to lethal tumor necrosis factor alpha (TNF-alpha) release upon encountering lipopolysaccharide (LPS). This explains acute GVHD symptoms.

Area of Science:

  • Immunology
  • Transplantation Biology

Background:

  • Macrophage (M phi) activation and tumor necrosis factor alpha (TNF-alpha) production are critical in graft-versus-host disease (GVHD).
  • TNF-alpha release by M phi requires priming (e.g., by interferon) followed by triggering (e.g., by lipopolysaccharide - LPS).

Purpose of the Study:

  • To investigate M phi activity and TNF-alpha production during GVHD.
  • To determine the role of M phi priming and LPS in GVHD pathogenesis.

Main Methods:

  • M phi activation state was examined in B6AF1 mice undergoing acute or nonlethal GVHD.
  • In vitro studies assessed M phi priming using LPS and TNF-alpha-sensitive cell lines.
  • Serum TNF-alpha and endogenous LPS levels were measured during GVHD.

Main Results:

  • Acute GVHD induced M phi priming, making them hyperresponsive to LPS.
  • LPS administration to GVHD mice caused lethal TNF-alpha release, unlike in normal mice.
  • Endogenous LPS was detected in acute GVHD mice, correlating with mortality.
  • M phi priming was more pronounced in acute GVHD than nonlethal GVHD.

Conclusions:

  • GVHD primes M phi via the allogeneic reaction.
  • Endogenous LPS then triggers primed M phi to produce TNF-alpha, causing acute GVHD symptoms.
  • This mechanism highlights a key pathway in GVHD pathogenesis.

Related Concept Videos